Exhibit 107
Calculation of Filing Fee Tables
Form S-3
(Form Type)
Xilio Therapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered and Carry Forward Securities
| | | | | | | | | | | | |
| Security | Security | Fee | Amount | Proposed | Maximum | Fee | Amount of | Carry | Carry | Carry | Filing Fee |
Newly Registered Securities | ||||||||||||
Fees to Be | Equity | Common Stock, $0.0001 par value per share | Other | 17,580,566 (1) | $1.016 (2) | $17,861,855.06 (2) | 0.00014760 | $2,636.41 | | | | |
Fees | — | — | — | — | — | — | — | — | | | | |
Carry Forward Securities | ||||||||||||
Carry | — | — | — | — | — | — | — | — | — | — | — | — |
| Total Offering Amounts | | $17,861,855.06 (2) | — | $2,636.41 | | | | | |||
| Total Fees Previously Paid | | | | — | | | | | |||
| Total Fee Offsets | | | | — | | | | | |||
| Net Fee Due | | | | $2,636.41 | | | | |
(1) | The shares of common stock will be offered for resale by the selling stockholders pursuant to the prospectus contained in the registration statement to which this exhibit is attached. The registration statement registers the resale of an aggregate of 17,580,566 shares of the Registrant’s common stock, which consists of (i) 1,953,125 outstanding shares of common stock and (ii) 15,627,441 shares of common stock issuable upon the exercise of outstanding pre-funded warrants. Pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”), the shares of common stock being registered hereunder include such indeterminate number of shares of common stock as may be issuable upon stock splits, stock dividends, or other distribution, recapitalization or similar events. |
(2) | This estimate is made pursuant to Rule 457(c) of the Securities Act solely for purposes of calculating the registration fee. The price per share and aggregate offering price are based upon the average of the high and low prices of the Registrant’s common stock on April 25, 2024, as reported on the Nasdaq Global Select Market. |